Skip to main content
. 2023 Feb 2;9(2):e13375. doi: 10.1016/j.heliyon.2023.e13375

Table 2.

Intraoperative, postoperative variables and study outcomes.

Non-transfusion group (n = 22) Transfusion group (n = 31) P
Intraoperative variables
Operation time (min) 46 (33.0–60.4) 58 (44.0–72.5) 0.067
Crystalloid (mL) 2000.0 (1800.0–2300.0) 1950.0 (1462.5–2375.0) 0.850
Colloid use 4 (18.1) 11 (32.3) 0.172
Urine output (mL) 50 (45.0–90.0) 60 (40.0–100.0) 0.926
Estimated blood loss (mL) 1000.0 (1000.0–1100.0) 1500.0 (1000.0–2375.0) 0.007
Transfusion
RBC, units 0 (0.0–0.0) 2.4 (2.0–5.8) <0.001
Massive transfusion (≥10 units) 0 (0.0) 4 (12.9) 0.132
FFP 0 (0.0) 11 (35.5) 0.001
PC 0 (0.0) 2 (6.5) 0.505
Postoperative variables
Analgesic use 16 (72.7%) 19 (61.3%) 0.391
Study outcomes
Postoperative NLR 6.8 (5.0–9.4) 12.2 (8.0–14.4) <0.001
Postoperative PLR 117.4 (90.4–161.3) 108.0 (90.4–172.9) 0.885
Postoperative RDW 13.9 (13.2–14.3) 14.6 (13.9–14.9) 0.002

Data are expressed as mean (standard deviation), number (%), or median (interquartile range). RBC, red blood cell; FFP, fresh frozen plasma; PC, platelet concentrates; NLR, neutrophil to lymphocyte ratio; PLR, platelet to lymphocyte ratio; RDW, red cell distribution width.